In 2021, Stacye Westington tripped over a rug, and as she lay on the floor in her Kingston home, she became aware that a glass she had been holding was broken. A shard was cutting her arm. It hurt.

Interest in ivermectin for kidney cancer has come primarily from preclinical studies. Authors of a review from China stated ...

Q3 2025 Earnings Call Transcript November 13, 2025 Vaxart, Inc. beats earnings expectations. Reported EPS is $-0.04, ...

Intellia Therapeutics finds itself navigating contrasting developments as regulatory challenges for one key program are ...

NEW ORLEANS — It is said, "A mother's love is a force that can move mountains." It was a year ago that we brought you the ...

Detailed price information for Coherus Oncology Inc (CHRS-Q) from The Globe and Mail including charting and trades.

The FDA has approved a groundbreaking blood test for colon cancer screening, offering a less invasive and more accessible ...

Net loss for the third quarter of 2025 was $74.1 million, compared to a net loss of $54.4 million for the third quarter of 2024. Net loss for the third quarter included non-cash share-based ...

Viking Therapeutics shares have delivered explosive gains this week, climbing to their highest level in ten months. The biotech firm's rally is being fueled ...

Operator: Welcome to Tivic Health Systems third quarter 2025 financial results and operational update conference call. This ...

Delta-8 THC is a cannabinoid, chemically similar to the more familiar Delta-9 tetrahydrocannabinol (Delta-9 THC), the main psychoactive component of cannabis. According to a review in the British ...

Lexicon Pharmaceuticals targets a turnaround with sotagliflozin, LX9851, pilavapadin, and partnerships offering multiple ...